Scholars Central

CommentaryPublished 5 Nov 2024

Liquid Tumors at a Glance: Innovations, Challenges and Future Directions in Hematologic Oncology

Authors: Ashraf Abdullah Saad

Advances in Medical Research

Volume 7 · Issue 1 · Pages 1–21

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hematologic malignancies, commonly referred to as liquid tumors, encompass a diverse group of cancers such as leukemias, lymphomas, and myelomas. Defined by unique genetic, molecular, and clinical characteristics, these diseases present significant challenges in diagnosis, treatment, and prognosis. Despite advances in therapeutic strategies-including immunotherapy, targeted therapies, and hematopoietic stem cell transplantation-patients with high-risk or relapsed disease often face poor outcomes. Notably, Multiple Myeloma (MM) remains an incurable plasma cell malignancy despite recent innovations, underscoring the need for more effective and durable treatment strategies. This article offers a comprehensive review of the classification, pathophysiology, and molecular features of liquid tumors, with a particular focus on emerging therapeutic approaches and unmet clinical needs. By addressing current challenges and future opportunities, this work seeks to contribute to the advancement of care for patients with these complex malignancies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Advances in Medical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Medical Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Ashraf Abdullah Saad”